News

Scripps News on MSN5d
FDA approves Merck’s Enflonsia to prevent RSV in infants
The Food and Drug Administration has approved a new drug from Merck designed to protect infants from respiratory syncytial ...
Pulmonology Advisor5d
Enflonsia Approved for RSV Disease Prevention in Infants
The FDA has approved Enflonsia (clesrovimab-cfor) for the prevention of RSV lower respiratory tract disease in neonates and ...
Medindia5d
FDA Approves ENFLONSIA to Shield Infants From RSV
In a major boost for infant health, the U.S. Food and Drug Administration (FDA) has approved ENFLONSIA ™ (clesrovimab-cfor), ...
Clinical Trials Arena6d
MSD’s Enflonsia receives FDA approval for RSV prophylaxis
MSD's Enflonsia (clesrovimab) has received US Food and Drug Administration (FDA) approval for the prevention of respiratory ...
New antibody shot could help protect babies from RSV
A newly approved shot could soon help protect babies from respiratory syncytial virus (RSV), the top cause of hospitalization ...
KGUN 96d
FDA approves Merck’s Enflonsia to prevent RSV in infants
Merck said Enflonsia is administered as a single 105 mg dose and provides protection for up to five months — the typical length of an RSV season. “Enflonsia combines dosing convenience with ...
Kennedy's picks for vaccine advisory panel raise concerns about anti-vaccine bias
Robert F. Kennedy Jr. announced a panel including vaccine skeptics, drawing criticism from public health leaders and ...
Medical Marketing & Media6d
Rx Rundown: BioNTech, Merck, RayzeBio and more
RayzeBio, the radiopharmaceutical unit of Bristol Myers Squibb, licensed an experimental drug and diagnostic agent for prostate cancer from Philochem AG for a $350 million upfront payment. Philochem ...